Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1 2Phase 1/2 1

Status

Completed 5

Sponsor Class

INDUSTRY 4NETWORK 1

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Gastrointestinal 1CNS 1Breast 1

Conditions

Neuroblastoma 1Colorectal Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Cyclophosphamide 741Cisplatin 688Gemcitabine 641Bevacizumab 616Carboplatin 605Paclitaxel 601Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 361Capecitabine 342Filgrastim 333Etoposide 330Dexamethasone 312Irinotecan 309pembrolizumab 280Leucovorin 274Cetuximab 268Cytarabine 242Erlotinib Hydrochloride 231Nivolumab 228Prednisone 227Trastuzumab 225Vincristine 221Bortezomib 221Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Completed × ABT751 × Clear all
NCT00436852 2019-07-17

ABT-751 in Treating Children With Neuroblastoma That Has Relapsed or Not Responded to Previous Treatment

Children's Oncology Group

Phase 2 Completed
92 enrolled 17 charts
CNS

Neuroblastoma

NCT00063102 2007-11-29

A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol or Taxotere) Therapy.

Abbott

Phase 2 Completed
40 enrolled
Breast

Breast Neoplasms

NCT00073112 2007-11-29

A Study of ABT-751 in Patients With Renal Cell Cancer

Abbott

Phase 2 Completed
60 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT00073138 2007-11-29

A Study of ABT-751 in Patients With Colorectal Cancer

Abbott

Phase 2 Completed
40 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT00073151 2007-11-29

A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer

Abbott

Phase 2 Completed
30 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡